All The Claims

1. A network for data communication between computing devices comprising:
a nonvolatile memory (NVM) unit;
a cartridge to receive the NVM unit, the cartridge comprising a wireless transmitter and a memory to hold routing information;
a conveyance system to transport the NVM unit and cartridge from a source computing device to a target computing device;
a physical network controller to control the conveyance system to transport the NVM unit and cartridge from a source computing device to a target computing device according to the routing information;
wherein the network is programmed for:
identifying parameters of a data transfer between the source computing device and the target computing device;
identifying communication paths between the source computing device and the target computing device, the communication paths comprised in the physical network;
selecting a communication path for the data transfer;
when a physical data transfer over the physical network is selected as a communication path for the data transfer, removing the nonvolatile memory (NVM) unit from the source computing device and placing the removed NVM unit in the cartridge;
programming the cartridge with transfer information;
transporting the NVM unit and cartridge through the physical network to the target computing device according to the transfer information;
connecting the NVM unit into the target computing device; and
in which selecting a communication path for the data transfer comprises:
evaluating at least two different communication paths for data transfer between the source computing device and a target computing device; and
determining when the physical data transfer is a most efficient communication path for the data transfer.
2. A physical network for data communication between computing devices comprising:
a nonvolatile memory (NVM) unit;
a cartridge to receive the NVM unit, the cartridge comprising a wireless transmitter and a memory to hold routing information;
a conveyance system to disconnect the NVM at a source computing device, transport the NVM unit and cartridge from the source computing device to a target computing device and connect the NVM at the target computing device;
a physical network controller to control the conveyance system to transport the NVM unit and cartridge from the source computing device to the target computing device according to the routing information; and
a control unit for determining, based on parameters of a data transfer, whether a physical data transfer via the NVM unit as transported by the conveyance system or an electronic data transfer via an electronic data connection between the source and target computing devices is a most efficient communication path for the data transfer.
3. A physical network for data communication between computing devices comprising:
a nonvolatile memory (NVM) unit;
a cartridge to receive the NVM unit, the cartridge comprising a wireless transmitter and a memory to hold routing information;
a conveyance system to transport the NVM unit and cartridge from a source computing device to a target computing device;
a physical network controller to control the conveyance system to transport the NVM unit and cartridge from a source computing device to a target computing device according to the routing information.
4. A method for communication between computing devices on the physical network of claim 3, the method comprising:
identifying parameters of a data transfer between the source computing device and the target computing device;
identifying communication paths between the source computing device and the target computing device, the communication paths comprised in the physical network;
selecting a communication path for the data transfer;
when a data transfer over the physical network is selected as a communication path for the data transfer, removing the nonvolatile memory (NVM) unit from the source computing device and placing the removed NVM unit in the cartridge;
programming the cartridge with transfer information;
transporting the NVM unit and cartridge through the physical network to the target computing device according to the transfer information; and
connecting the NVM unit into the target computing device.
5. The method of claim 4, in which the data transfer over the physical network comprises one of: a system back up, data staging, system restore, index update, or recovery after failure.
6. The method of claim 4, in which selecting a communication path for the data transfer comprises determining that an amount of time to make the data transfer over the physical network is less than an amount of time required to make the data transfer using an alternative method.
7. The method of claim 4, in which selecting a communication path for the data transfer comprises determining an amount of energy required to make the data transfer over the physical network is less than an amount of energy required to make a data transfer using an alternative method.
8. The method of claim 4, in which programming the cartridge with transfer information comprises:
generating transfer information comprising at least one of: routing information, meta-data describing the data being transferred, cartridge information, authentication information, and target computer information; and
storing the transfer information in the cartridge.
9. The method of claim 8, in which the cartridge comprises a communication capability for communicating the transfer information while the cartridge and NVM unit are being transported.
10. The method of claim 9, which the communication capability comprises one of: a wired communication capability and a wireless communication capability; in which the wireless communication capability comprises one of radio frequency or microwave data transmission.
11. The method of claim 4, in which transporting the nonvolatile memory unit through the physical network to the target computing device according to the transfer information comprises removing the NVM unit containing desired data from physical and electrical connection with the source computing device and automatically routing the NVM unit through the physical network to the target computing device.
12. The method of claim 4, in which physically transporting the NVM unit through the physical network to the target computing device according to the transfer information comprises receipt of the transfer information by a robot and manipulation of the NVM unit by the robot.
13. The physical network of claim 3, further comprising a robot to remove the NVM unit from the source computing device and place the NVM unit in the cartridge.
14. The physical network of claim 3, in which the conveyance system comprises:
a track;
trolley to travel on the track and to contain a plurality of NVM units; and
a robot attached to the trolley to remove one of the NVM units from the trolley and to place the NVM unit in electrical contact with the target computing device.
15. The physical network of claim 3, in which the conveyance system comprises:
a conveyor belt to transport the NVM unit and cartridge; and
a robot to remove the NVM unit and cartridge from the conveyor belt and electrically connect the NVM unit to the target device.
16. The physical network of claim 3, wherein said cartridge comprises:
an interior cavity to receive the NVM unit; and
a reversible locking mechanism to lock the NVM unit in place within the interior cavity, the reversible locking mechanism comprising one of a spring-loaded mechanism and an electrical actuator.
17. The physical network of claim 3, wherein the memory of the cartridge further comprises an identification of the NVM unit and data contained on the NVM unit.
18. The physical network of claim 3, wherein the NVM unit comprises a number of NVM chips for storing data, a controller and an interface.
19. The physical network of claim 3, further comprising a control unit for determining whether a particular data transfer is most quickly performed by the physical network or by a wired or wireless data network.
20. The physical network of claim 3, further comprising a control unit for determining whether a particular data transfer will consume less energy being made by the physical network or by a wired or wireless data network.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A method of coating a plurality of elongate members utilizing an apparatus having a batch handling portion, a coating portion, and an alignment portion, the batch handling portion having a plurality of flimsy member securement portions with an array of elongate flexible members dangling from each flimsy member securement portion, each array having a distal ends in a state of disorganization, the method comprising the steps of:
engaging each array with the alignment portion adjacent the flimsy member securement portion before the elongate members are coated,
moving the alignment portion down the array toward the distal ends whereby the distal ends are taken out of the state of disorganization and are put into an aligned state.
2. A method of sequentially coating a plurality of batches of elongate flimsy members, each batch comprising an array of elongate flimsy members secured to a separate flimsy member securement portion, each flimsy member having an attached end and a dangling end, the method comprising the steps of:
a) attaching a batch to a batch handling portion whereby the dangling ends of the elongate flimsy members are in an unorganized arrangement,
b) positioning a guide portion proximate the flimsy member securement portion in an open configuration, then laterally moving the guide portion to a closed position to simultaneously individually engage the flimsy members at a location where the flimsy members are in an organized configuration to discretely position each elongate flimsy member of the batch,
c) lowering the guide portion along the array of flimsy members whereby the dangling ends of the elongate flimsy members are brought from a disorganized arrangement into an organized arrangement,
d) inserting the array of elongate flimsy members into a coating portion,
e) removing the array from the coating portion and conveying the batch from the batch handling portion,
f) repeating the above steps sequentially with additional batches of elongate flimsy members.
3. The method of claim 2 whereby the step b occurs after step a and step b comprises insertion of the guide portion laterally into the array of flimsy members.
4. The method of claim 3 wherein the guide portion comprises opposing cooperating members and the insertion of the guide portion occurs from opposing sides of the array of flimsy members.
5. A method of coating a batch of elongate flimsy members, the batch comprising a plurality of elongate flimsy members, each having a proximal end, an intermediate portion, and a distal end, the method comprising the steps of:
securing each of the elongate flimsy members at the proximal end of each flimsy member in an array such that the distal ends of the elongate flimsy members are dangling downward in an unaligned disorganized manner;
securing the array to a vertically movable carnage whereby the array may be moved collectively downward;
positioning an array alignment portion to the batch proximate the carriage in an open configuration nearer to the proximal ends of the elongate flimsy members than the distal ends of the members;
moving the array alignment portion into a closed configuration to simultaneously individually engage each of the elongage flimsy members with the array alignment portion at a location where the elongate flimsy members are in an organized configuration such that each of the members is positionally constrained therein;
lowering the array alignment portion downwardly with respect to the batch whereby the distal ends of the elongate flimsy members are aligned and positioned from a disorganized configuration into an organized configuration for insertion into inlets.
6. The method of claim 5 further comprising the step of lowering the batch downwardly with the distal ends aligned such that the distal ends are inserted into the inlets and the elongate flimsy members are coated.
7. The method of claim 6 further comprising the step of moving the array alignment portion to a non-constraining position before the elongate flimsy members are coated.
8. The method of claim 5 wherein the array alignment portion comprises a comb member and the method further comprises the step of moving the comb member from a non-constraining position to a constraining position before lowering the array alignment portion, the constraining position where each of the elongate flimsy members is positionally constrained therein.
9. A method of coating an array of elongate flimsy members, the array comprising a plurality of elongate flimsy members, each elongate flimsy member having a proximal end, an intermediate portion, and a distal end, the distal ends of the array being in a disorganized state, the method comprising the steps of:
supporting the array on a support in a batch handling portion whereby the elongate flimsy members are dangling downwardly with the distal ends unaligned, moving an array guide portion from proximate the support downwardly with respect to the array whereby the distal ends of the elongate flimsy members are put into alignment with an array of inlets of a coating portion, and lowering the array of elongate flimsy members into the coating portion, wherein the array guide portion comprises a plurality of comb members and the method further comprising the step of moving the plurality of comb members from a non-alignment position to an alignment position before lowering the array guide portion from proximate the support downwardly and wherein the method further comprises the step of moving the plurality of comb members by rotating said comb members about a plurality of horizontal axes.

What is claimed is:

1. An isolated polypeptide comprising the mature form of an amino acid sequenced selected from the group consisting of SEQ ID NO: 2n, wherein n is an integer between 1 and 102.
2. An isolated polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 2n, wherein n is an integer between 1 and 102.
3. An isolated polypeptide comprising an amino acid sequence which is at least 95% identical to an amino acid sequence selected from the group consisting of SEQ ID NO: 2n, wherein n is an integer between 1 and 102.
4. An isolated polypeptide, wherein the polypeptide comprises an amino acid sequence comprising one or more conservative substitutions in the amino acid sequence selected from the group consisting of SEQ ID NO: 2n, wherein n is an integer between 1 and 102.
5. The polypeptide of claim 1 wherein said polypeptide is naturally occurring.
6. A composition comprising the polypeptide of claim 1 and a carrier.
7. A kit comprising, in one or more containers, the composition of claim 6.
8. The use of a therapeutic in the manufacture of a medicament for treating a syndrome associated with a human disease, the disease selected from a pathlology associated with the polypeptide of claim 1, wherein the therapeutic comprises the polypeptide of claim 1.
9. A method for determining the presence or amount of the polypeptide of claim 1 in a sample, the method comprising:
(a) providing said sample;
(b) introducing said sample to an antibody that binds immunospecifically to the polypeptide; and
(c) determining the presence or amount of antibody bound to said polypeptide, thereby determining the presence or amount of polypeptide in said sample.
10. A method for determining the presence of or predisposition to a disease associated with altered levels of expression of the polypeptide of claim 1 in a first mammalian subject, the method comprising:
a) measuring the level of expression of the polypeptide in a sample from the first mammalian subject; and
b) comparing the expression of said polypeptide in the sample of step (a) to the expression of the polypeptide present in a control sample from a second mammalian subject known not to have, or not to be predisposed to, said disease,
wherein an alteration in the level of expression of the polypeptide in the first subject as compared to the control sample indicates the presence of or predisposition to said disease.
11. A method of identifying an agent that binds to the polypeptide of claim 1, the method comprising:
(a) introducing said polypeptide to said agent; and
(b) determining whether said agent binds to said polypeptide.
12. The method of claim 11 wherein the agent is a cellular receptor or a downstream effector.
13. A method for identifying a potential therapeutic agent for use in treatment of a pathology, wherein the pathology is related to aberrant expression or aberrant physiological interactions of the polypeptide of claim 1, the method comprising:
(a) providing a cell expressing the polypeptide of claim 1 and having a property or function ascribable to the polypeptide;
(b) contacting the cell with a composition comprising a candidate substance; and
(c) determining whether the substance alters the property or function ascribable to the polypeptide;
whereby, if an alteration observed in the presence of the substance is not observed when the cell is contacted with a composition in the absence of the substance, the substance is identified as a potential therapeutic agent.
14. A method for screening for a modulator of activity of or of latency or predisposition to a pathology associated with the polypeptide of claim 1, said method comprising:
(a) administering a test compound to a test animal at increased risk for a pathology associated with the polypeptide of claim 1, wherein said test animal recombinantly expresses the polypeptide of claim 1;
(b) measuring the activity of said polypeptide in said test animal after administering the compound of step (a); and
(c) comparing the activity of said polypeptide in said test animal with the activity of said polypeptide in a control animal not administered said polypeptide, wherein a change in the activity of said polypeptide in said test animal relative to said control animal indicates the test compound is a modulator activity of or latency or predisposition to, a pathology associated with the polypeptide of claim 1.
15. The method of claim 14, wherein said test animal is a recombinant test animal that expresses a test protein transgene or expresses said transgene under the control of a promoter at an increased level relative to a wild-type test animal, and wherein said promoter is not the native gene promoter of said transgene.
16. A method for modulating the activity of the polypeptide of claim 1, the method comprising contacting a cell sample expressing the polypeptide of claim 1 with a compound that binds to said polypeptide in an amount sufficient to modulate the activity of the polypeptide.
17. A method of treating or preventing a pathology associated with the polypeptide of claim 1, the method comprising administering the polypeptide of claim 1 to a subject in which such treatment or prevention is desired in an amount sufficient to treat or prevent the pathology in the subject.
18. The method of claim 17, wherein the subject is a human.
19. A method of treating a pathological state in a mammal, the method comprising administering to the mammal a polypeptide in an amount that is sufficient to alleviate the pathological state, wherein the polypeptide is a polypeptide having an amino acid sequence at least 95% identical to a polypeptide comprising the amino acid sequence selected from the group consisting of SEQ ID NO: 2n, wherein n is an integer between 1 and 102 or a biologically active fragment thereof.
20. An isolated nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of SEQ ID NO: 2n1, wherein n is an integer between 1 and 102.
21. The nucleic acid molecule of claim 20, wherein the nucleic acid molecule is naturally occurring.
22. A nucleic acid molecule, wherein the nucleic acid molecule differs by a single nucleotide from a nucleic acid sequence selected from the group consisting of SEQ ID NO: 2n1, wherein n is an integer between 1 and 102.
23. An isolated nucleic acid molecule encoding the mature forth of a polypeptide having an amino acid sequence selected from the group consisting, of SEQ ID NO: 2n, wherein n is an integer between 1 and 102.
24. An isolated nucleic acid molecule comprising a nucleic acid selected from the group consisting of 2n1, wherein n is an integer between 1 and 102.
25. The nucleic acid molecule of claim 20, wherein said nucleic acid molecule hybridizes under stringent conditions to the nucleotide sequence selected from the group consisting of SEQ ID NO: 2n1, wherein n is an integer between 1 and 102, or a complement of said nucleotide sequence.
26. A vector comprising the nucleic acid molecule of claim 20.
27. The vector of claim 26, further comprising a promoter operably linked to said nucleic acid molecule.
28. A cell comprising the vector of claim 26.
29. An antibody that immunospecifically binds to the polypeptide of claim 1.
30. The antibody of claim 29, wherein the antibody is a monoclonal antibody.
31. The antibody of claim 29, wherein the antibody is a humanized antibody.
32. A method for determining the presence or amount of the nucleic acid molecule of claim 20 in a sample, the method comprising:
(a) providing said sample;
(b) introducing said sample to a probe that binds to said nucleic acid molecule; and
(c) determining the presence or amount of said probe bound to said nucleic acid molecule,
thereby determining the presence or amount of the nucleic acid molecule in said sample.
33. The method of claim 32 wherein presence or amount of the nucleic acid molecule is used as a marker for cell or tissue type.
34. The method of claim 33 wherein the cell or tissue type is cancerous.
35. A method for determining the presence of or predisposition to a disease associated with altered levels of expression of the nucleic acid molecule of claim 20 in a first mammalian subject, the method comprising:
a) measuring the level of expression of the nucleic acid in a sample from the first mammalian subject; and
b) comparing the level of expression of said nucleic acid in the sample of step (a) to the level of expression of the nucleic acid present in a control sample from a second mammalian subject known not to have or not be predisposed to, the disease;
wherein an alteration in the level of expression of the nucleic acid in the first subject as compared to the control sample indicates the presence of or predisposition to the disease.
36. A method of producing the polypeptide of claim 1, the method comprising culturing a cell under conditions that lead to expression of the polypeptide, wherein said cell comprises a vector comprising an isolated nucleic acid molecule comprising, a nucleic acid sequence selected from the group consisting of SEQ ID NO: 2n1, wherein n is an integer between 1 and 102.
37. The method of claim 36 wherein the cell is a bacterial cell.
38. The method of claim 36 wherein the cell is an insect cell.
39. The method of claim 36 wherein the cell is a yeast cell.
40. The method of claim 36 wherein the cell is a mammalian cell.
41. A method of producing, the polypeptide of claim 2, the method comprising culturing a cell under conditions that lead to expression of the polypeptide, wherein said cell comprises a vector comprising an isolated nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of SEQ ID NO: 2n1, wherein n is an integer between 1 and 102.
42. The method of claim 41 wherein the cell is a bacterial cell.
43. The method of claim 41 wherein the cell is an insect cell.
44. The method of claim 41 wherein the cell is a yeast cell.
45. The method of claim 41 wherein the cell is a mammalian cell.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A method of manufacturing a semiconductor device including SRAM cell units each comprising a data holding section comprising a pair of a first driving transistor and a second driving transistor and a pair of a first load transistor and a second load transistor, a data write section comprising a pair of a first access transistor and a second access transistor, and a data read section comprising a third access transistor and a third driving transistor, wherein each of the transistors comprises a semiconductor layer projecting upward from a base plane, a gate electrode extending from a top to opposite side surfaces of the semiconductor layer so as to stride the semiconductor layer, a gate insulating film interposed between the gate electrode and the semiconductor layer, and a pair of a source area and a drain area provided in the semiconductor layer, the method comprising:
patterning a semiconductor layer to form a semiconductor layer pattern including a striped pattern in which long semiconductor layers extending in a first direction and having an equal width in a second direction perpendicular to the first direction are arranged at equal intervals;
removing a part of the striped pattern;
forming a gate insulating film on side surfaces of the remaining long semiconductor layers;
depositing a gate electrode material and patterning the gate electrode material deposited film to form a gate electrode extending from a top to opposite side surfaces of each of the long semiconductor layers along the second direction so as to stride the long semiconductor layer; and
introducing impurities into each long semiconductor layer to form sourcedrain areas.
2. The method of manufacturing the semiconductor device according to claim 1, wherein the semiconductor layer pattern is formed to be line symmetric to each of four sides of a rectangular unit boundary corresponding to a SRAM cell unit boundary serving as a symmetry axis.
3. The method of manufacturing the semiconductor device according to claim 1, wherein
in the formation of the semiconductor layer pattern, a band-like pattern is formed, the band-like pattern crossing the long semiconductor layers and having a first-direction width greater than the second-direction width of each of the long semiconductor layers; and
in the removal of a part of the striped pattern, a part of the band-like pattern is also removed to form a pad semiconductor layer having a second-direction width greater than a second-direction width of each of the long semiconductor layers for connecting a contact connected with an upper layer wire to the pad semiconductor layer.
4. The method of manufacturing the semiconductor device according to claim 1, further comprising forming a cap insulating layer on the semiconductor layer, wherein the semiconductor layer and the cap insulating layer are patterned to form the semiconductor layer pattern with the cap insulating layer formed thereon.
5. The method of manufacturing the semiconductor device according to claim 1, wherein the semiconductor layer provided on a base insulating layer is patterned to form the semiconductor layer pattern provided on the base insulating layer.
6. The method of manufacturing the semiconductor device according to claim 1, further comprising patterning a semiconductor substrate as the semiconductor layer to form the semiconductor layer pattern and then forming a separating insulating layer on the semiconductor substrate, and removing a top surface-side part of the separating insulating layer to expose the semiconductor layer pattern so that the semiconductor layer pattern projects upward from the remaining separating insulating film.